Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Comprehensive Microscopy and Peripheral Blood Smear Curriculum for Hematology Fellows

Lauren G Banaszak, Matthew James Brunner, Chad Guenther, Eliot C. Williams

Blood (2023) 142 (Supplement 1): 7202.

https://doi.org/10.1182/blood-2023-185126

Published: 2023

Journal Articles

Angiogenic Blockade with Bevacizumab Does Not Increase Response to Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Myeloma

Andrew T Humbert, Rachel Cook, MS, MD, Thomas McFarland, Ronald Go, MD, Stephanie Markovina, MD, Shigeki Miyamoto, PhD, Eliot C. Williams, MD, PhD, Fotios Asimakopoulos, MBBChir, PhD, Jill Kolesar, PhD, Michael A. Thompson, MD, PhD, Kyungmann Kim, Natalie Callander, MD

Blood (2012) 120 (21): 5041.

https://doi.org/10.1182/blood.V120.21.5041.5041

Published: 2012

Journal Articles

HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery

Thomas L. Ortel, MD, PhD, Ian Welsby, MD, David F Kong, MD, John A. Heit, M.D., Elizabeth Krakow, MD, Nicole Whitlatch, MD, Gowthami M. Arepally, MD, Grace Lee, MD, Shahar Bar-Yosef, MD, Eliot C. Williams, MD, PhD

Blood (2011) 118 (21): 1159.

https://doi.org/10.1182/blood.V118.21.1159.1159

Published: 2011

Journal Articles

The Addition of Bevacizumab (B) to Lenalidomide and Low Dose Dexamethasone Does Not Significantly Increase Response in Relapsed or Refractory Multiple Myeloma (NCI#7317).

Natalie Scott Callander, MD, Stephanie Markovina, BA, Mark B. Juckett, MD, Elizabeth Wagner, MA, Jill Kolesar, Walter Longo, Eliot C. Williams, MD, PhD, Kyungmann Kim, Jae Werndli, BSc, MSc, Shigeki Miyamoto, PhD

Blood (2009) 114 (22): 3885.

https://doi.org/10.1182/blood.V114.22.3885.3885

Published: 2009

Journal Articles

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Wael Saber, MD, MS, Teng Moua, MD, Eliot C. Williams, MD, PhD, Melina Verso, MD, Giancarlo Agnelli, MD, Stephen Couban, MD, Annie Young, RN, Marcello De Cicco, MD, Roberto Biffi, MD, Cornelis J. van Rooden, MD, Menno V. Huisman, MD, PhD, Daniele Fagnani, MD, Claudio Cimminiello, MD, Marco Moia, MD, Stephen P. Povoski, MD, Sharp Malak, MD, MPH, Agnes Y. Lee, MD, MSc, FRCPC

Blood (2008) 112 (11): 3814.

https://doi.org/10.1182/blood.V112.11.3814.3814

Published: 2008

NARROW

A Comprehensive Microscopy and Peripheral Blood Smear Curriculum for Hematology Fellows

Angiogenic Blockade with Bevacizumab Does Not Increase Response to Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Myeloma

HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery

The Addition of Bevacizumab (B) to Lenalidomide and Low Dose Dexamethasone Does Not Significantly Increase Response in Relapsed or Refractory Multiple Myeloma (NCI#7317).

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Email alerts

ASH Publications

American Society of Hematology

A Comprehensive Microscopy and Peripheral Blood Smear Curriculum for Hematology Fellows

Angiogenic Blockade with Bevacizumab Does Not Increase Response to Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Myeloma

HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery

The Addition of Bevacizumab (B) to Lenalidomide and Low Dose Dexamethasone Does Not Significantly Increase Response in Relapsed or Refractory Multiple Myeloma (NCI#7317).

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only